Clinical or Bedside: Hapter Three
Clinical or Bedside: Hapter Three
Clinical or Bedside: Hapter Three
With the clinical bedside tests for total brain failure, the clinician
examines the comatose patient for any signs of brainstem function
(See Figure 4). The functional status of this part of the brain is im-
portant for several reasons. First, the functions that depend on the
brainstem are central to the basic work of the organism as a whole.
This has already been noted with respect to the brainstem’s (par-
ticularly, the medulla’s) involvement in breathing. Brainstem
function is also critical to an organism’s conscious life. O ne part of
the brainstem, known as the “reticular activating system,” is essen-
tial for maintaining a state of wakefulness, which is a prerequisite
for any of the activities associated with consciousness.
* For a clinical case study of a patient who showed all the signs of total brain
failure after a snake bite but then recovered after receiving an antidote, see R.
Agarwal, N. Singh, and D . G upta, “Is the Patient Brain-D ead?” E merg M ed J 23,
no. 1 (2006): e5.
32 | CO NTRO VERSIES IN THE D ETERMINATIO N O F D EATH
cance in most cases, for the brainstem is the most resilient part of
the brain as a whole. As will be elaborated in Part III, if a brain in-
jury has progressed to the point at which the brainstem retains no
function, it has probably ravaged the more fragile parts of the brain
as well. Thus, the bedside tests for brainstem function are tests for
the extent of destruction both to the brainstem and to the parts of
the brain “above the brainstem”— the so-called “higher centers.” *
How, then, do the clinical tests determine the status of the brain-
stem? O ne marker of brainstem function has already been explored
in depth: the signal that is sent from the respiratory centers to the
muscles of respiration. Thus, the patient’s drive to breathe must be
tested with an apnea test. “Apnea” is the technical term for an in-
ability to breathe. Although all patients who receive ventilator
support need the machine’s help to breathe, most are not so injured
that they have no drive to breathe whatsoever. The purpose of the
apnea test for total brain failure is to establish that the patient has no
drive to bring air into the body even when the sensors in the brain-
stem are receiving an unambiguous signal that breathing is required.
Recall from the previous discussion that these sensors serve to trig-
ger movement of the muscles of respiration when high levels of
carbon dioxide in the blood are detected. In the apnea test, then,
the ventilator is removed and the level of carbon dioxide in the pa-
tient’s bloodstream is permitted to increase beyond the point that
* The exception to the rule discussed in the text is a case where a primary lesion
of the brainstem leads to the diagnostic signs that usually indicate total brain fail-
ure. In such a case, the condition of the brainstem is not itself a reliable indicator
of the condition of the higher centers of the brain. Among those who accept the
neurological standard for determining death, there is controversy about the vital
status of the patient about whom all that is k nown is the condition of the brain-
stem. See S. Laureys, “Science and Society: D eath, Unconsciousness and the
Brain,” N at R ev N eurosci 6, no. 11 (2005): 901-02; J. L. Bernat, “O n Irreversibility
as a Prerequisite for Brain D eath D etermination,” A dv E x p M ed Biol 550 (2004):
166; and C. Pallis and D . H. Harley, A BC of Brainstem D eath, Second ed. (London:
BMJ Publishing G roup, 1996): 11-12. For the purposes of this report, such pa-
tients are excluded from the group considered to have “total brain failure.”
CHAPTER THREE | 33
* The patient is prepared for this test by receiving, in advance, an elevated level of
circulating oxygen that will prevent any further damage to tissues while the test is
being carried out. Some inconsistencies in the way the apnea test is carried out in
different places— including whether it is required at all in some countries— have
been documented. For more information, see E. F. Wijdicks, “Brain D eath
Worldwide: Accepted Fact but No G lobal Consensus in D iagnostic Criteria,”
N eurology 58, no. 1 (2002): 20-5; R. Vardis and M. M. Pollack, “Increased Apnea
Threshold in a Pediatric Patient with Suspected Brain D eath,” C rit C are M ed 26,
no. 11 (1998): 1917-9; and R. J. Brilli and D . Bigos, “Apnea Threshold and Pedi-
atric Brain D eath,” C rit C are M ed 28, no. 4 (2000): 1257.